Research programme: serotonin 1A/dopamine agonists - Bayer
Alternative Names: Serotonin 1A/dopamine agonists research programme - BayerLatest Information Update: 26 Mar 2010
At a glance
- Originator Bayer
- Class
- Mechanism of Action 5-HT1A serotonin receptor agonists; Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 26 Mar 2010 Discontinued - Preclinical for Parkinson's disease in Germany (unspecified route)
- 19 Mar 2001 Preclinical development for Parkinson's disease in Germany (Unknown route)